Anagenics Ltd

AU:AN1 Australia Household & Personal Products
Market Cap
$3.66 Million
AU$5.91 Million AUD
Market Cap Rank
#36715 Global
#1408 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.70
About

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pac… Read more

Anagenics Ltd (AN1) - Total Liabilities

Latest total liabilities as of December 2025: AU$1.82 Million AUD

Based on the latest financial reports, Anagenics Ltd (AN1) has total liabilities worth AU$1.82 Million AUD as of December 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Anagenics Ltd - Total Liabilities Trend (2006–2025)

This chart illustrates how Anagenics Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Anagenics Ltd Competitors by Total Liabilities

The table below lists competitors of Anagenics Ltd ranked by their total liabilities.

Liability Composition Analysis (2006–2025)

This chart breaks down Anagenics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.10 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anagenics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anagenics Ltd (2006–2025)

The table below shows the annual total liabilities of Anagenics Ltd from 2006 to 2025.

Year Total Liabilities Change
2025-06-30 AU$2.28 Million -34.66%
2024-06-30 AU$3.48 Million +57.09%
2023-06-30 AU$2.22 Million -52.18%
2022-06-30 AU$4.64 Million +62.14%
2021-06-30 AU$2.86 Million -43.70%
2020-06-30 AU$5.08 Million +29.04%
2019-06-30 AU$3.93 Million -19.59%
2018-06-30 AU$4.89 Million +20.01%
2017-06-30 AU$4.08 Million +49.64%
2016-06-30 AU$2.72 Million +14.79%
2015-06-30 AU$2.37 Million +200.19%
2014-06-30 AU$790.70K +14.83%
2013-06-30 AU$688.56K +60.59%
2012-06-30 AU$428.78K -45.30%
2011-06-30 AU$783.90K +112.26%
2010-06-30 AU$369.31K -23.66%
2009-06-30 AU$483.80K -75.64%
2008-06-30 AU$1.99 Million -37.60%
2007-06-30 AU$3.18 Million +505.60%
2006-06-30 AU$525.45K --